Search results for: '5 mm NMR'
Methylene Chloride-d2
1-3 weeksRef. Packaging I.E.(%) Price Add to... D023B 10 x 0.75 mL 99.8% D €103.80D023F 1 x 25 mL 99.8% D €228.30D023FE 1 x 10 mL 99.8% D €88.70Show 1 more products Toluol-d8
1-3 weeksRef. Packaging I.E.(%) Price Add to... D005BB 2 x 0.75 mL 99.6% D €27.10D005F 1 x 25 mL 99.6% D €204.30D005FE 1 x 10 mL 99.6% D €90.10Show 1 more products Benzene-d6
1-3 weeksRef. Packaging I.E.(%) Price Add to... D001B 10 x 0.75 mL 99.5% D €91.80D001ES 5 x 10 mL Septum Vial 99.5% D €368.10D001F 1 x 25 mL 99.5% D €168.30Show 3 more products Methanol-d4
1-3 weeksRef. Packaging I.E.(%) Price Add to... D024B 10 x 0.75 mL 99.8% D €79.70D024ES 5 x 10 mL Septum Vial 99.8% D €249.40D024F 1 x 25 mL 99.8% D €144.20Show 6 more products Acetonitrile-d3
1-3 weeksRef. Packaging I.E.(%) Price Add to... D021B 10 x 0.75 mL 99.8% D €78.20D021EAS 1 x 10 mL Septum Vial 99.8% D €73.80D021FD 1 x 5 mL 99.8% D €34.80Show 2 more products Dimethylsulfoxide-d6
1-3 weeksRef. Packaging I.E.(%) Price Add to... D010B 10 x 0.75 mL 99.8% D €37.70D010ES 5 x 10 mL Septum Vial 99.8% D €139.80D010F 1 x 25 mL 99.8% D €73.80Show 10 more products Acetone-d6
1-3 weeksRef. Packaging I.E.(%) Price Add to... D009B 10 x 0.75 mL 99.8% D €51.10D009ES 5 x 10 mL Septum Vial 99.8% D €153.30D009F 1 x 25 mL 99.8% D €75.20Show 4 more products 13C, 15N, D fMLF
CCND10073P5
3 - 6 weeks• 5 mg
• N-formyl-methionyl-leucyl-phenylalanine (fMLF)
• Labeling: 13C, 15N, D
• CrystallizedPTFE caps for 10 mm Tube, Pack of 25
WG-1264-10€310.502-4 weeks• For Precision Tube Only
• Material: PTFEPTFE caps for 3 mm Tube, Pack of 25
WG-1264-3€145.402-4 weeks• For Precision Tube Only
• Material: PTFEPTFE caps for 4 mm Tube, Pack of 25
WG-1264-4€145.402-4 weeks• For Precision Tube Only
• Material: PTFE13C, 15N, D Microcrystalline SH3
CCND10053P5
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, DPrecision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 64 mm
NE-295-V-5€190.404 - 6 weeksFor Varian Probes1Α,25-Dihydroxyvitamin D2 (6,19,19-d3) Solution
CD6051P
2 - 4 weeks• 5 mg/mL In Ethanol
• 99% D, 95% CP1Α,25-Dihydroxyvitamin D3 (6,19,19-d3) Solution
CD6102P
2 - 4 weeks• 5 mg/mL In Ethanol
• 97% D, 96% CPCetyltrimethylammonium bromide alpha-d2 (CTAB, alpha-d2)
CD1196P
4 - 8 weeks• CTAB α-d2
• Deuteration: 98 %
• Chemical purity > 99 %Lauryl N,N-dimethylamine N-oxide-d31 (LDAO-d31)
CD5000P025€2,300.004 - 8 weeks• LDAO, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical Purity > 99 %1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine (6:0 D6PC-d22)
CD5010P025€1,520.004 - 8 weeks• D6PC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-diheptanoyl-d26-sn-glycero-3-phosphocholine (7:0 D7PC-d26)
CD5011P025€1,520.004 - 8 weeks• D7PC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine (14:0 DMPC-d54)
CD5012P025€1,140.004 - 8 weeks• DMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphocholine (14:0-d27-14:0 DMPC)
CD5013P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphocholine (14:0-14:0-d27 DMPC)
CD5014P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-sn-glycero-3-phosphocholine-d72 (14:0 DMPC-d72)
CD5015P
4 - 8 weeks• DMPC, Perdeuterated1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine (16:0 DPPC-d62)
CD5016P025€1,140.004 - 8 weeks• DPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dihexanoyl-d22-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (6:0 D6PC-d22,d9)
CD5017P025€3,800.004 - 8 weeks• D6PC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-diheptanoyl-d26-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (7:0 D7PC-d26,d9)
CD5018P025€3,800.004 - 8 weeks• D7PC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (14:0 DMPC-d54,d9)
CD5019P025€3,800.004 - 8 weeks• DMPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dihexanoyl-d22-sn-glycero-3-phosphoglycerol (6:0 D6PG-d22)
CD5020P025€2,860.004 - 8 weeks• D6PG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-diheptanoyl-d26-sn-glycero-3-phosphoglycerol, (7:0 D7PG-d26)
CD5021P025€2,860.004 - 8 weeks• D7PG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-3-phosphoglycerol (14:0 DMPG-d54)
CD5022P025€2,860.004 - 8 weeks• DMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dipalmitoyl-d62-sn-glycero-3-phosphoglycerol (16:0 DPPG-d62)
CD5023P025€2,860.004 - 8 weeks• DPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %
• 100mg1,2-dipalmitoyl-d62-sn-glycero-3-phosphocholine-N,N,N-trimethyl-d9 (16:0 DPPC-d62,d9)
CD5024P025€3,800.004 - 8 weeks• DPPC, Deuterated on both acyl chains & choline methyls
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1-palmitoyl-d31-2-palmitoyl-sn-glycero-3-phosphocholine (16:0-d31-16:0 DPPC)
CD5025P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1-palmitoyl-2-palmitoyl-d31-sn-glycero-3-phosphocholine (16:0-16:0-d31 DPPC)
CD5026P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1,2-diheptanoyl-sn-glycero-3-phosphocholine-d44 (7:0 D7PC-d44)
CD5028P
4 - 8 weeks• D7PC, Perdeuterated1-lauroyl-2-hydroxy-d23-sn-glycero-3-phosphoglycerol (12:0 LLPG-d23)
CD5030P025€3,800.004 - 8 weeks• LLPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphoglycerol (14:0 LMPG-d27)
CD5031P025€3,800.004 - 8 weeks• LMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphoglycerol (16:0 LPPG-d31)
CD5032P025€3,800.004 - 8 weeks• LPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphocholine (14:0 LMPC-d27)
CD5036P025€2,860.004 - 8 weeks• LMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphocholine, (16:0 LPPC-d31)
CD5037P025€2,860.004 - 8 weeks• LPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %n-decylphosphocholine-d34 (Fos-Choline-10-d34)
CD5040P025€2,860.004 - 8 weeks• Fos-Choline-10-d34, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %n-tetradecylphosphocholine-d42 (Fos-Choline-14-d42)
CD5041P025€2,860.004 - 8 weeks• Fos-Choline-14-d42, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphoglycerol (14:0-d27-14:0 DMPG)
CD5042P
4 - 8 weeks• DMPG, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoglycerol (14:0-14:0-d27 DMPG)
CD5052P
4 - 8 weeks• DMPG, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphethanolamine (14:0-d27-14:0 DMPE)
CD5053P
4 - 8 weeks• DMPE, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dihexanoyl-d22-sn-glycero-3-phosphoethanolamine (6:0 D6PE-d22)
CD5061P025€2,860.004 - 8 weeks• D6PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-diheptanoyl-d26-sn-glycero-3-phosphoethanolamine, (7:0 D7PE-d26)
CD5062P025€2,860.004 - 8 weeks• D7PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-3-phosphoethanolamine (14:0 DMPE-d54)
CD5063P025€2,860.004 - 8 weeks• DMPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dipalmitoyl-d62-sn-glycero-3-phosphoethanolamine (16:0 DPPE-d62)
CD5064P025€2,860.004 - 8 weeks• DPPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %n-octyl b-D-glucopyranoside-d17 (OG-d17)
CD5065P025€2,860.004 - 8 weeks• OG, Deuterated on the octyl tail
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoethanolamine (14:0-14:0-d27 DMPE)
CD5067P
4 - 8 weeks• DMPE, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-d58 (14:0 DMPE-d58)
CD5068P
4 - 8 weeks• DMPE, Perdeuterated1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-d31-18:1-d33 POPC)
CD5071P025€7,410.004 - 8 weeks• POPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-d31-18:1-d33 POPG)
CD5072P025€8,350.004 - 8 weeks• POPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1,2-dioleoyl-d66-sn-glycero-3-phosphocholine (18:1 DOPC-d66)
CD5074P025€7,410.004 - 8 weeks• DOPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-d31-2-oleyl-d33-sn-glycero-phosphoserine (16:0-d31-18:1-d33 POPS)
CD5075P
4 - 8 weeks• POPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine (18:1-d33-18:1-d33 DOPE)
CD5076P
4 - 8 weeks• DOPE, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-phosphoserine (14:0 DMPS-d54)
CD5077P
4 - 8 weeks• DMPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-decanoyl-d19-rac-glycerol-d5 (10-MAG-d24)
CD5078P025€2,100.004 - 8 weeks• 10-MAG, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %1,2-dimyristoyl-d54-sn-glycero-3-phosphoserine-d3 (14:0 DMPS-d54,d3)
CD5079P
4 - 8 weeks• DMPS, Deuterated on both acyl chains and serine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphoglycerol (16:0-d31-18:1 POPG)
CD5082P
4 - 8 weeks• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-18:1-d33 POPG)
CD5083P
4 - 8 weeks• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %1-palmitoyl-2-oleoyl-sn-glycero-phosphoglycerol-d74 (16:0-18:1 POPG-d74)
CD5084P
4 - 8 weeksPOPG, Perdeuterated1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphocholine (16:0-d31-18:1 POPC)
CD5091P
4 - 8 weeks• POPC, Deuterated on palmitate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-18:1-d33 POPC)
CD5092P
4 - 8 weeks• POPC, Deuterated on oleate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine-d82 (16:0-18:1 POPC-d82)
CD5093P
4 - 8 weeksPOPC, Perdeuterated1,2-dioleoyl-d66-sn-glycero-3-phosphoglycerol (18:1 DOPG-d66)
CD5096P
4 - 8 weeks• DOPG, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine-d4 (18:1 DOPE-d70)
CD5098P
4 - 8 weeks• DOPE, Deuterated on both acyl chains and ethanolamine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %Dodecylphosphocholine-d38 (DPC-d38)
CD600P025€640.004 - 8 weeks• DPC, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %2-Ketobutyric Acid-4-13C, 4-d1
CCD1400P1€2,070.002 - 4 weeks• Sodium Salt Hydrate
• 99% 13C, 97% D
• Contains 5-10% CD2H
• 1 gTE102 Low Temperature Aqueous Cell Spectroscopic Quality
WG-808-S-Q€3,510.302-4 weeksFor All TE102 or TE01113C, 15N Calbindin in Solution
CCN10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D13C, 15N Calbindin in Solution
CCN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D13C, 15N Microcrystalline GB1
CCN10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N13C, 15N Microcrystalline GB1
CCN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N13C, 15N GB1 in Solution
CCN10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N13C, 15N GB1 in Solution
CCN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N13C, 15N MBP in Solution
CCN10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N13C, 15N MBP in Solution
CCN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N13C, 15N SH3 in Solution
CCN10054P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N13C, 15N SH3 in Solution
CCN10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N13C, 15N Microcrystalline Ubiquitin
CCN10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N13C, 15N Microcrystalline Ubiquitin
CCN10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N13C, 15N Ubiquitin in Solution
CCN10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N13C 15N Ubiquitin in Solution
CCN10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N13C, 15N, D Calbindin in Solution
CCND10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D13C, 15N, D Calbindin in Solution
CCND10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D13C, 15N, D Microcrystalline GB1
CCND10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D13C, 15N, D Microcrystalline GB1
CCND10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 13C, 15N, D13C, 15N, D GB1 in Solution
CCND10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D13C, 15N, D GB1 in Solution
CCND10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 13C, 15N, D13C, 15N, D MBP in Solution
CCND10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D13C, 15N, D MBP in Solution
CCND10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 13C, 15N, D13C, 15N, D Microcrystalline Ubiquitin
CCND10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D13C, 15N, D Microcrystalline Ubiquitin
CCND10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D13C, 15N, D Ubiquitin in Solution
CCND10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D13C, 15N, D Ubiquitin in Solution
CCND10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 13C, 15N, D15N Calbindin in Solution
CN10014P10
3 - 6 weeks• 10 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D15N Calbindin in Solution
CN10014P20
3 - 6 weeks• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: 13C, 15N, D15N Microcrystalline GB1
CN10033P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N15N Microcrystalline GB1
CN10033P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: 15N15N GB1 in Solution
CN10034P10
3 - 6 weeks• 10 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N15N GB1 in Solution
CN10034P20
3 - 6 weeks• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: 15N15N MBP in Solution
CN10044P10
3 - 6 weeks• 10 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N15N MBP in Solution
CN10044P20
3 - 6 weeks• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: 15N15N SH3 in Solution
CN10054P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N15N SH3 in Solution
CN10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N15N Microcrystalline Ubiquitin
CN10063P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N15N Microcrystalline Ubiquitin
CN10063P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N15N Ubiquitin in Solution
CN10064P10
3 - 6 weeks• 10 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N15N Ubiquitin in Solution
CN10064P20
3 - 6 weeks• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: 15N13C, 15N, D Microcrystalline SH3
CCND10053P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D13C, 15N, D Microcrystalline SH3
CCND10053P20
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D13C, 15N, D SH3 in Solution
CCND10054P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D13C, 15N, D SH3 in Solution
CCND10054P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 13C, 15N, D15N Microcrystalline SH3
CN10053P10
3 - 6 weeks• 10 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15N15N Microcrystalline SH3
CN10053P20
3 - 6 weeks• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: 15Nn-dodecyl b-D-maltopyranoside-d25 (DDM-d25)
CD5066P025€2,860.004 - 8 weeks• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %Tool Kit for 50 mL HR-MAS rotor
B2950€45.403-6 weeksFor use with 50 µL HR-MAS rotor only (HZ07213)
Kit contains:
• One extration tool
• One scredriver
• One depth gauge96 slots storage rack for Kel-F inserts
B5771€541.803-6 weeks• Ideal for storing, freezing and tracking samples
• Sturdy anodized aluminum construction render this rack autoclavable and resistant to commonly used chemicalsTool for HR-MAS spacer
HZ04875€26.803-6 weeksFor use with 4mm HR-MAS rotor only (HZ05537, HZ05538, HZ07213)150 mL Suprasil Large Volume Dewar Flask
WG-850-B-Q€2,044.102-4 weeksFor Bruker and Jeol instruments150 mL Suprasil Nitrogen Dewar Flask
WG-850-Q€2,044.102-4 weeksFor Micro-Now, Radio-Pan and Agilent instruments150 mL Suprasil Offset Nitrogen Dewar Flask
WG-853-B-Q€2,102.102-4 weeksFor Bruker and Jeol instrumentsPrecision Thin Wall Quartz Sleeve, 5.5 x 6.0 x 58.6 mm
NE-295-5A€138.504 - 6 weeksFor Bruker Late Model ProbesPrecision Thin Wall Quartz Sleeve, 5.8 x 6.1 x 54.5 mm
NE-295-5B€195.604 - 6 weeksFor Bruker Dual Flow Probes10mm Symmetrical Microtube Matched with DMSO
DMS-010
2 - 4 weeks• For Bruker and Jeol probe
• 10mm Symmetrical Microtube
• Matched with DMSO